Delineating germline, tumor and extrinsic factors driving mucosal melanoma risk and response

Ended Project Grant Awarded Last action

Award ID
W81XWH2210974
Recipient
Awarding agency
Obligated
$427,817

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Houston, TX 77030, USA

Award details come from USAspending.gov.

About this award

The University of Texas MD Anderson Cancer Center will receive $427,817 under a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to delineate germline, tumor and extrinsic factors driving mucosal melanoma risk and response. Through September 2025, MD Anderson researchers will investigate medical solutions for mucosal melanoma through innovative and impactful research supported by this award. The Military Medical Research and Development program aims to transform military and public health through basic, applied and advanced biomedical research investigations.

Quick answers

Who received award W81XWH2210974?

W81XWH2210974 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on September 30, 2022.

How much is award W81XWH2210974 worth?

$427,817 has been obligated on W81XWH2210974.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award